Rank | cMap name | Enrichment | p | Specificity | Percent non-null | Description |
---|---|---|---|---|---|---|
1 | MG-262 | − 0.992 | 0 | 0 | 100 | Inhibitor of the chymotryptic activity of the proteasome |
2 | Anisomycin | − 0.981 | 0 | 0.0085 | 100 | Antibiotic, inhibiting eukaryotic protein synthesis |
3 | Digoxin | − 0.978 | 0 | 0 | 100 | Cardiac glycoside, inhibiting the Na+/K+ ATPase |
4 | Ouabain | − 0.977 | 0 | 0.0088 | 100 | Cardiac glycoside, inhibiting the Na+/K+ ATPase |
5 | Cephaeline | − 0.955 | 0 | 0.0121 | 100 | Inducing vomiting by stimulating the stomach lining |
6 | Emetine | − 0.953 | 0 | 0.0118 | 100 | Inducing vomiting by stimulating the stomach lining |
7 | Mebendazole | − 0.943 | 0 | 0 | 100 | Broad-spectrum antihelminthic |
8 | Phenoxybenzamine | − 0.941 | 0 | 0.0091 | 100 | Alpha-adrenoceptor antagonist, used as an anti-hypertensive |
9 | Digitoxigenin | − 0.937 | 0 | 0 | 100 | Cardiac glycoside, inhibiting the Na+/K+ ATPase |
10 | Thioridazine | − 0.701 | 0 | 0.043 | 80 | A first generation antipsychotic drug |
11 | 15-Delta prostaglandin J2 | − 0.634 | 0 | 0.0301 | 86 | Anti-inflammatory lipid mediator |
12 | LY-294002 | − 0.323 | 0.00002 | 0.2945 | 54 | PI3K-AKT inhibitor |
13 | Lomustine | − 0.921 | 0.00006 | 0 | 100 | An alkylating nitrosourea compound used in chemotherapy |
14 | Digoxigenin | − 0.879 | 0.00008 | 0 | 100 | Derivative of the cardiac glycoside digoxin |
15 | Thapsigargin | − 0.964 | 0.00012 | 0.0258 | 100 | An inhibitor of sarco endoplasmic reticulum Ca2+ ATPase (SERCA) |